Employing three machine learning algorithms (LASSO, RF, and SVM-RFE), we identified AKR1B10, IGFL2, WNK2, SLAMF7, and CCR7 as potential biomarkers and therapeutic targets for HS treatment. The gene discussed is IGFL2; the disease is histiocytic sarcoma.